O'BRIEN PATRICK (General Counsel) sold 9.4% of their position (49.49K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.12M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−560.00
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−560.00
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−560.00
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−560.00
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−560.00
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−4.37K
Price / share
$61.20
Trade value
$267.32K
% of position
Common Stock
Shares
−6.16K
Price / share
$62.23
Trade value
$383.59K
% of position
Common Stock
Shares
−13.45K
Price / share
$62.96
Trade value
$846.87K
% of position
Common Stock
Shares
−11.84K
Price / share
$63.84
Trade value
$755.99K
% of position
Common Stock
Shares
−2.70K
Price / share
$64.44
Trade value
$173.99K
% of position
Common Stock
Shares
−900.00
Price / share
$66.01
Trade value
$59.41K
% of position
Common Stock
Shares
−313.00
Price / share
$68.00
Trade value
$21.28K
% of position
Common Stock
Shares
−600.00
Price / share
$61.12
Trade value
$36.67K
% of position
Common Stock
Shares
−900.00
Price / share
$62.25
Trade value
$56.02K
% of position
Common Stock
Shares
−5.87K
Price / share
$62.91
Trade value
$369.47K
% of position
Common Stock
Shares
−2.34K
Price / share
$64.04
Trade value
$149.60K
% of position
Common Stock
Shares
−46.00
Price / share
$68.00
Trade value
$3.13K
% of position
Net shares
−52.29K
Net value
-$3.12M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | G · Gift | −560.00 | — | — | 0.1% | 527.20K | 526.64K |
| Common Stock Direct | 12/31/2025 | G · Gift | −560.00 | — | — | 0.1% | 526.64K | 526.08K |
| Common Stock Direct | 12/31/2025 | G · Gift | −560.00 | — | — | 0.1% | 526.08K | 525.52K |
| Common Stock Direct | 12/31/2025 | G · Gift | −560.00 | — | — | 0.1% | 525.52K | 524.96K |
| Common Stock Direct | 12/31/2025 | G · Gift | −560.00 | — | — | 0.1% | 524.96K | 524.40K |
| Common Stock Direct | 1/5/2026 | S · Sale | −4.37K | $61.20 | $267.32K | 0.8% | 524.40K | 520.03K |
| Common Stock Direct | 1/5/2026 | S · Sale | −6.16K | $62.23 | $383.59K | 1.2% | 520.03K | 513.87K |
| Common Stock Direct | 1/5/2026 | S · Sale | −13.45K | $62.96 | $846.87K | 2.6% | 513.87K | 500.42K |
| Common Stock Direct | 1/5/2026 | S · Sale | −11.84K | $63.84 | $755.99K | 2.4% | 500.42K | 488.58K |
| Common Stock Direct | 1/5/2026 | S · Sale | −2.70K | $64.44 | $173.99K | 0.6% | 488.58K | 485.88K |
| Common Stock Direct | 1/5/2026 | S · Sale | −900.00 | $66.01 | $59.41K | 0.2% | 485.88K | 484.98K |
| Common Stock Direct | 1/5/2026 | S · Sale | −313.00 | $68.00 | $21.28K | 0.1% | 484.98K | 484.66K |
| Common Stock Direct | 1/5/2026 | S · Sale | −600.00 | $61.12 | $36.67K | 0.1% | 484.66K | 484.06K |
| Common Stock Direct | 1/5/2026 | S · Sale | −900.00 | $62.25 | $56.02K | 0.2% | 484.06K | 483.16K |
| Common Stock Direct | 1/5/2026 | S · Sale | −5.87K | $62.91 | $369.47K | 1.2% | 483.16K | 477.29K |
| Common Stock Direct | 1/5/2026 | S · Sale | −2.34K | $64.04 | $149.60K | 0.5% | 477.29K | 474.95K |
| Common Stock Direct | 1/5/2026 | S · Sale | −46.00 | $68.00 | $3.13K | 0.0% | 474.95K | 474.91K |
| Total | −52.29K | -$3.12M | ||||||